EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evidence for therapeutic use of cannabidiol for nail-patella syndrome-induced pain in a real-world pilot study

Thibaud Lebret, Séverine Hatton, Jacques Callebert, Valérie Cormier-Daire, Céline Greco iD

Scientific Reports · 2024

DOI: 10.1038/s41598-024-79239-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Thibaud Lebret und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain and Palliative Care, Hôpital Necker-Enfants Malades, AP-HP, 149 rue de Sèvres, Paris, France. Hauptthemen laut MEDLINE: Cannabidiol, Nail-Patella Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ecole de l’Inserm Liliane-Bettencourt, Fondation Bettencourt-Schueller, INSERM DR PARIS IDF CENTRE NORD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nail-patella syndrome (NPS) is a rare genetic disease characterized by dysplastic nails, patella abnormalities, skeletal malformation, and chronic pain. Although chronic pain in NPS is mainly due to bone and musculoskeletal symptoms, it can also result from neurological dysfunction. Conventional analgesics are often insufficient to relieve NPS-associated chronic pain. Cannabinoids, which act on the serotonergic and/or noradrenergic pain systems, may therefore represent valuable non-psychoactive alternatives for managing pain in these patients. The effectiveness and safety of synthetic cannabidiol (CBD) for the management of NPS-associated pain was assessed using real-world data from a pilot cohort of patients with NPS who received a 3-month treatment with oral CBD. The treatment (median dose of 900 mg/day) was associated with a significant reduction in pain intensity (mean score of 7.04 ± 0.24 at initiation versus 4.04 ± 0.38 at 3 months, N = 28, p < 0.0001), which correlated with changes in the peripheral concentration of noradrenaline (r = 0.705, 95% CI [0.44-0.86], p < 0.0001). Health-related quality of life and other NPS-associated symptoms also improved in most patients. CBD treatment was well tolerated and no elevations in liver enzyme levels were reported. Synthetic CBD therefore appears to be a safe and effective treatment option for managing NPS-associated chronic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolNail-Patella SyndromeHumansPilot ProjectsFemaleMaleAdultMiddle AgedQuality of LifeChronic PainTreatment OutcomeAnalgesicsYoung AdultPain Management

Stichwörter der Autor:innen

CannabinoidsChronic painNail-patella syndromeNoradrenalinePain managementSerotonin

Substanzen

CannabidiolAnalgesics

Autor:innen und Institutionen

  • Department of Pain and Palliative Care, Hôpital Necker-Enfants Malades, AP-HP, 149 rue de Sèvres, Paris, France.
  • Laboratoire de Biochimie et Biologie Moléculaire, Hôpital Lariboisière, AP-HP, Paris, France.
  • Université Paris Cité, INSERM UMR-S 1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France.
  • Service de médecine génomique des maladies rares, Centre de référence des maladies osseuses constitutionnelles, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
  • Université Paris Cité, INSERM UMR 1163, Institut Imagine, Paris, France.
  • Department of Pain and Palliative Care, Hôpital Necker-Enfants Malades, AP-HP, 149 rue de Sèvres, Paris, France. celine.greco@inserm.fr.

ORCID-Profile: Céline Greco

Förderung

  • Ecole de l’Inserm Liliane-Bettencourt
  • Fondation Bettencourt-Schueller
  • INSERM DR PARIS IDF CENTRE NORD

Zitieren

APA

Lebret, T., Hatton, S., Callebert, J., Cormier-Daire, V., & Greco, C. (2024). Evidence for therapeutic use of cannabidiol for nail-patella syndrome-induced pain in a real-world pilot study. Scientific Reports. https://doi.org/10.1038/s41598-024-79239-9

Vancouver

Lebret T, Hatton S, Callebert J, Cormier-Daire V, Greco C. Evidence for therapeutic use of cannabidiol for nail-patella syndrome-induced pain in a real-world pilot study. Scientific Reports. 2024. doi:10.1038/s41598-024-79239-9

BibTeX
@article{Lebret2024,
  author = {Lebret, Thibaud and Hatton, Séverine and Callebert, Jacques and Cormier-Daire, Valérie and Greco, Céline},
  title = {Evidence for therapeutic use of cannabidiol for nail-patella syndrome-induced pain in a real-world pilot study},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-79239-9}
}
Kostenlos starten →